Skip to content
TrialScanner

NCT05220722

Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

Phase 1/Phase 2TerminatedTLSILead

Registry record

Lead sponsor
TriSalus Life Sciences, Inc.
Conditions
Hepatocellular Carcinoma; Intrahepatic Cholangiocarcinoma
Primary completion
Jul 31, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05220722 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05220722: Pressure Enabled Delivery of... | TrialScanner